datopotamab,Pembrolizumab,Carboplatin,Cisplatin
Daiichi Sankyo,AstraZeneca,merck
['datopotamab', 'sclc', 'nsclc', 'pivotal trial', '$dsnky', '$azn']
the search is on for early signals in front-line nsclc for datopotamab, the trop2 adc that is already in three pivotal trials. my take on the #asco23 data: $azn $dsnky 
Pharma and biotech reporter, found a home at Evaluate Vantage.